SCIOS HOLDS ANNUAL MEETING
SCIOS HOLDS ANNUAL MEETING MOUNTAIN VIEW, Calif., May 6 /PRNewswire/ -- Scios Inc.
(NASDAQ: SCIO) announced the re-election of John W. Culligan, chairman, Richard L. Casey, Myron Du Bain, Steven D. Goldby, and Robert W. Schrier, M.D., to the board of directors at its annual stockholders meeting held May 5, 1992. The matters submitted for stockholder approval were adopted, including the 1992 Equity Incentive Plan, and the selection of Coopers & Lybrand as independent auditors for fiscal 1992 was ratified by the stockholders.
Scios Inc. (formerly California Biotechnology Inc.) is a biopharmaceutical company engaged in the discovery, development and commercialization of novel human therapeutics. Scios focuses its efforts in three areas -- cardiopulmonary disease, tissue repair, and metabolic disorders. The company develops and commercializes products on a proprietary basis and in collaboration with established pharmaceutical companies. -0- 5/6/92 /CONTACT: Virgina Walker of Scios, 415-940-6631 or 415-966-1550; or Robert Gottlieb of Feinstein Partners, 617-577-8110, for Scios/ (SCIO) CO: Scios, Inc. ST: California IN: MTC SU: PER
SH -- NE004 -- 6961 05/06/92 09:45 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||May 6, 1992|
|Previous Article:||HADSON ENERGY RESOURCES ANNOUNCES FIRST QUARTER EARNINGS AND CASH FLOWS|
|Next Article:||LORAIN ASSEMBLY NAMES ASSISTANT PLANT MANAGER|